Key Points
- Major shareholder Charles Jobson bought 16,753 shares of The Joint Corp. (NASDAQ:JYNT) on Jan. 23 at $10.00 per share, increasing his direct stake to 1,638,424 shares (a 1.03% rise) valued at about $16.38 million.
- JYNT stock opened at $9.73 and is trading lower (down ~4.7%), with a market cap of ~$144.7M, a negative P/E (-162.14), and the company recently reported an EPS beat ($0.02 vs. -$0.01 expected) despite negative margins.
- Analyst coverage is mixed (one Buy, one Hold, one Sell) with an average target of $17.00, and institutional investors hold roughly 76.9% of the outstanding shares.
The Joint Corp. (NASDAQ:JYNT - Get Free Report) major shareholder Charles Jobson purchased 16,753 shares of the company's stock in a transaction on Friday, January 23rd. The shares were purchased at an average cost of $10.00 per share, with a total value of $167,530.00. Following the transaction, the insider directly owned 1,638,424 shares in the company, valued at $16,384,240. This trade represents a 1.03% increase in their ownership of the stock. The acquisition was disclosed in a document filed with the SEC, which is available through this hyperlink. Major shareholders that own more than 10% of a company's shares are required to disclose their sales and purchases with the SEC.
Joint Trading Down 4.7%
JYNT stock opened at $9.73 on Wednesday. The stock has a market capitalization of $144.69 million, a price-to-earnings ratio of -162.14 and a beta of 1.29. The firm's 50-day moving average price is $9.01 and its two-hundred day moving average price is $9.53. The Joint Corp. has a 12-month low of $7.50 and a 12-month high of $13.47.
Joint (NASDAQ:JYNT - Get Free Report) last posted its earnings results on Friday, November 7th. The company reported $0.02 earnings per share for the quarter, topping analysts' consensus estimates of ($0.01) by $0.03. The company had revenue of $13.38 million during the quarter, compared to analyst estimates of $13.36 million. Joint had a negative net margin of 1.78% and a negative return on equity of 0.98%. Equities analysts predict that The Joint Corp. will post 0.11 EPS for the current year.
Wall Street Analysts Forecast Growth
JYNT has been the topic of several research reports. Weiss Ratings reaffirmed a "sell (e+)" rating on shares of Joint in a research report on Thursday, January 22nd. B. Riley downgraded Joint from a "buy" rating to a "hold" rating in a report on Friday, November 7th. One research analyst has rated the stock with a Buy rating, one has issued a Hold rating and one has given a Sell rating to the company. According to MarketBeat.com, the company has an average rating of "Hold" and an average target price of $17.00.
Get Our Latest Report on Joint
Institutional Inflows and Outflows
Large investors have recently added to or reduced their stakes in the stock. BNP Paribas Financial Markets boosted its holdings in Joint by 104.7% in the third quarter. BNP Paribas Financial Markets now owns 2,935 shares of the company's stock worth $28,000 after acquiring an additional 1,501 shares in the last quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. raised its position in shares of Joint by 25.9% in the 2nd quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 8,244 shares of the company's stock worth $95,000 after purchasing an additional 1,698 shares during the last quarter. JPMorgan Chase & Co. raised its position in shares of Joint by 32.3% in the 2nd quarter. JPMorgan Chase & Co. now owns 7,412 shares of the company's stock worth $86,000 after purchasing an additional 1,810 shares during the last quarter. Verus Capital Partners LLC boosted its stake in Joint by 1.7% in the 3rd quarter. Verus Capital Partners LLC now owns 113,426 shares of the company's stock worth $1,082,000 after purchasing an additional 1,947 shares in the last quarter. Finally, Nisa Investment Advisors LLC grew its position in Joint by 5,141.9% during the 2nd quarter. Nisa Investment Advisors LLC now owns 2,254 shares of the company's stock valued at $26,000 after purchasing an additional 2,211 shares during the last quarter. Hedge funds and other institutional investors own 76.88% of the company's stock.
Joint Company Profile
(
Get Free Report)
The Joint Chiropractic, Inc, doing business as Joint (NASDAQ: JYNT), is a franchisor and operator of outpatient chiropractic clinics in the United States. Under its flagship The Joint Chiropractic brand, the company offers membership-based, cash-focused spinal adjustment services designed to promote accessible, routine care for neck and back discomfort. By removing insurance requirements and offering walk-in visits, Joint aims to streamline the patient experience and reduce cost barriers to ongoing chiropractic treatment.
Joint's growth strategy centers on partnering with franchisees to expand its network of clinics.
Read More
This instant news alert was generated by narrative science technology and financial data from InsiderTrades.com in order to provide readers with the fastest and most accurate reporting. Please send any questions or comments about this story to [email protected].
